Ciclesonide comparison with fluticasone in mild persistent asthma
Not Applicable
- Conditions
- Asthma.Asthma, unspecified
- Registration Number
- IRCT201201028597N1
- Lead Sponsor
- Massih Daneshvari hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 356
Inclusion Criteria
Ladies and gentlemen between 12 and 75 years as the definitive diagnosis of asthma is confirmed as mild persistent asthma: (Symptoms more than two days per week but less than daily incidence, symptoms at night more than two nights in month but less thatn every night, FEV1 = 80% predicted, FEV1 Variability% 20 -% 30 and the use of B2 agonists short acting more than two days a week but less than daily).
Exclusion criteria: A) Having any of the criteria for moderate persistent asthma B) Pregnancy - Breastfeeding C) sensitivity to corticosteroids D) other lung diseases like COPD E) use of systemic corticosteroids in acute asthma attacks during two months before the run in period
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced expiratory volume in first second(FEV1). Timepoint: Before intervention and then 2,4, 8, 16 and 24 weeks after start of intervention. Method of measurement: Spirometry.
- Secondary Outcome Measures
Name Time Method